Facebook reports earnings after the bell on Wednesday and all eyes are on its changes to the News Feed. Jeff Tomasulo, CEO at Vespula Capital and Jason Moser, Analyst at The Motley Fool join The Long and The Short to discuss.
The billion dollar question is whether or not the new News Feed will impact ad dollars. Facebook CEO Mark Zuckerberg admitted that because of changes to the News Feed he expects the time people spend on Facebook and some measurements of engagement to go down. Tomasulo says the stock is up 34% in the last 12 months, yet you have CEO who's looking to change the company's main revenue stream. It worries investors and they are going to be looking for guidance this upcoming earnings report.
Plus, what is the fate of WhatsApp and Messenger? Facebook spent a lot of money on the acquisition of WhatsApp and investors are wondering where the product stands. Moser says Facebook is trying to pivot away from the spotlight of "fake news" and more toward the reason people use its platforms: to connect.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Scott Trench, host of the BiggerPockets Money Podcast, explores how recent rate cuts, high borrowing costs, and mortgage rates are reshaping U.S. real estate.
